IFM Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.3M | Buy |
84,397
+9,772
| +13% | +$4.69M | 0.28% | 64 |
|
|
2026
Q1 | $36.7M | Buy |
74,625
+2,071
| +3% | +$1.12M | 0.31% | 61 |
|
|
2025
Q4 | $42M | Buy |
72,554
+505
| +0.7% | +$286K | 0.35% | 45 |
|
|
2025
Q3 | $33.4M | Sell |
72,049
-446
| -0.6% | -$208K | 0.29% | 60 |
|
|
2025
Q2 | $29.4M | Buy |
72,495
+2,976
| +4% | +$1.24M | 0.28% | 66 |
|
|
2025
Q1 | $34.6M | Sell |
69,519
-315
| -0.5% | -$171K | 0.37% | 44 |
|
|
2024
Q4 | $36.3M | Sell |
69,834
-6,613
| -9% | -$3.64M | 0.37% | 44 |
|
|
2024
Q3 | $47.3M | Sell |
76,447
-746
| -1% | -$442K | 0.45% | 34 |
|
|
2024
Q2 | $42.7M | Sell |
77,193
-230
| -0.3% | -$132K | 0.43% | 36 |
|
|
2024
Q1 | $45M | Buy |
77,423
+116
| +0.2% | +$65.1K | 0.49% | 32 |
|
|
2023
Q4 | $41M | Sell |
77,307
-687
| -0.9% | -$333K | 0.5% | 35 |
|
|
2023
Q3 | $39.5M | Buy |
77,994
+2,677
| +4% | +$1.43M | 0.52% | 31 |
|
|
2023
Q2 | $39.3M | Buy |
75,317
+3,018
| +4% | +$1.63M | 0.51% | 35 |
|
|
2023
Q1 | $41.7M | Buy |
72,299
+2,336
| +3% | +$1.32M | 0.63% | 26 |
|
|
2022
Q4 | $38.5M | Buy |
69,963
+3,832
| +6% | +$2.03M | 0.65% | 27 |
|
|
2022
Q3 | $33.5M | Buy |
66,131
+733
| +1% | +$410K | 0.61% | 29 |
|
|
2022
Q2 | $35.5M | Buy |
65,398
+3,882
| +6% | +$2.14M | 0.62% | 30 |
|
|
2022
Q1 | $36.3M | Buy |
61,516
+10,164
| +20% | +$5.84M | 0.56% | 31 |
|
|
2021
Q4 | $34.3M | Sell |
51,352
-714
| -1% | -$446K | 0.63% | 24 |
|
|
2021
Q3 | $29.7M | Buy |
52,066
+12
| +0% | +$6.59K | 0.62% | 26 |
|
|
2021
Q2 | $26.3M | Buy |
52,054
+9,395
| +22% | +$4.43M | 0.54% | 36 |
|
|
2021
Q1 | $19.5M | Buy |
42,659
+4,440
| +12% | +$2.12M | 0.52% | 38 |
|
|
2020
Q4 | $17.8M | Buy |
38,219
+5,223
| +16% | +$2.45M | 0.57% | 35 |
|
|
2020
Q3 | $14.6M | Buy |
32,996
+3,630
| +12% | +$1.5M | 0.61% | 33 |
|
|
2020
Q2 | $10.6M | Sell |
29,366
-12,243
| -29% | -$4.1M | 0.55% | 37 |
|
|
2020
Q1 | $11.9M | Sell |
41,609
-1,251
| -3% | -$394K | 0.53% | 41 |
|
|
2019
Q4 | $13.9M | Sell |
42,860
-59
| -0.1% | -$17.9K | 0.49% | 40 |
|
|
2019
Q3 | $12.5M | Buy |
42,919
+14,813
| +53% | +$4.24M | 0.46% | 44 |
|
|
2019
Q2 | $8.25M | Buy |
28,106
+2,297
| +9% | +$633K | 0.47% | 41 |
|
|
2019
Q1 | $7.06M | Buy |
25,809
+2,486
| +11% | +$619K | 0.45% | 48 |
|
|
2018
Q4 | $5.22M | Buy |
23,323
+2,149
| +10% | +$504K | 0.42% | 50 |
|
|
2018
Q3 | $5.17M | Buy |
21,174
+3,054
| +17% | +$703K | 0.39% | 57 |
|
|
2018
Q2 | $3.75M | Buy |
18,120
+5,691
| +46% | +$1.21M | 0.35% | 59 |
|
|
2018
Q1 | $2.57M | Buy |
12,429
+1,267
| +11% | +$266K | 0.37% | 58 |
|
|
2017
Q4 | $2.12M | Buy |
11,162
+218
| +2% | +$41.8K | 0.33% | 64 |
|
|
2017
Q3 | $2.07M | Buy |
10,944
+275
| +3% | +$49.8K | 0.35% | 62 |
|
|
2017
Q2 | $1.86M | Buy |
10,669
+2,659
| +33% | +$447K | 0.33% | 67 |
|
|
2017
Q1 | $1.23M | Buy |
8,010
+3,020
| +61% | +$462K | 0.31% | 73 |
|
|
2016
Q4 | $704K | Buy |
+4,990
| New | +$736K | 0.33% | 77 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
IFM Investors's TMO Position: Q2 2026 in Review
IFM Investors increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $4.69M and bringing the position to 84,397 shares worth $42.3M. The position accounts for 0.28% of the portfolio, ranked #64.
IFM Investors first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $47.3M in Q3 2024. 770 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- IFM Investors held 84,397 shares of Thermo Fisher Scientific worth $42.3M as of Q2 2026.
- IFM Investors bought 9,772 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.69M.
- Thermo Fisher Scientific made up 0.28% of IFM Investors's portfolio in Q2 2026, its #64 holding.
- IFM Investors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's Thermo Fisher Scientific position peaked at $47.3M in Q3 2024.
- 770 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.